Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
/in International Publications, IOZK Veröffentlichungen /von 2017-10-24 / Sci Rep 2017 10;7(1):13902MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2017-10-20 / Biochem. Biophys. Res. Commun. 2017 12;494(1-2):13-19Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2017-10-19 / Eur Urol Focus 2018 04;4(3):442-454Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside
/in Exosome, International Publications /von 2017-10-18 / Biochim Biophys Acta Rev Cancer 2017 Dec;1868(2):538-563Serum selenium levels predict survival after breast cancer
/in International Publications, Micronutrients /von 2017-10-17 / Breast Cancer Res Treat 2018 01;167(2):591-598Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids
/in Exosome, International Publications /von 2017-10-03 / Biomaterials 2018 Jan;150:112-124Dendritic cells based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications, Pancreatic Cancer /von 2017-10-01 / Am J Cancer Res 2017;7(10):2091-2102Dendritic cell therapy in melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-10-01 / Ann Transl Med 2017 Oct;5(19):386
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de